Methylene Blue: Clinical Trials

30 trials of Methylene Blue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 4 unknown, 3 not yet recruiting, 3 recruiting. 30 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 230Completed 18, Unknown 4, Not yet recruiting 3, Recruiting 3, Terminated 1, Withdrawn 1
Phase 34Completed 2, Not yet recruiting 1, Recruiting 1
Phase 11Completed 1

Follow Methylene Blue: new trials by email Literature Review of Methylene Blue trials Research Report on Methylene Blue

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
Methylene Blue, Lipid Emulsion, Insertion of optical fiber - Abscess
Phase 2Not yet recruitingUniversity of Rochester1502027-07-152026-11-17
A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses
Standard of care breast abscess drainage, Methylene Blue, Lipid Emulsion - Breast Abscess
Phase 2Not yet recruitingUniversity of Rochester502027-07-012026-08-19
Early Methylene Blue in the Microhemodynamics of Septic Patients
Methylene blue infusion - Septic Shock, Hypoperfusion
Phase 2 / Phase 3RecruitingCentro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva502026-01-092026-03-27
Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer
methylene blue injection - Rectal Cancers
Phase 2RecruitingPeking University Cancer Hospital & Institute262025-11-252026-09-22
Methylene Blue Treatment of Chronic Hepatitis B Virus Infection
Methylene Blue - Chronic HBV Infection
Phase 2RecruitingFondazione Epatocentro Ticino102025-09-012026-08-21
Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock
Methylene Blue, Placebo - Neonatal Sepsis, Shock, Septic
Phase 2 / Phase 3Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh1302024-03-152024-03-12
Low Dose Versus High Dose Methylene Blue in Septic Patients
Normal saline, Methylene Blue low dose, Methylene Blue high dose - Septic Shock
Phase 2 / Phase 3CompletedNational Cancer Institute, Egypt902023-08-012024-07-05
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation - Surgical Site Infections, Nosocomial Infection
Phase 2CompletedOndine Biomedical Inc.3222022-02-042022-08-22
Methylene Blue for the Prevention of Hypotension During Hemodialysis
Methylene Blue, Control - Acute Kidney Injury, Shock
Phase 2CompletedFederal University of São Paulo2612021-10-212026-04-17
COVID-19 Methylene Blue Antiviral Treatment
Methylene Blue, Saline nasal spray - Covid19
Phase 2CompletedIrkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences242021-08-062022-02-09
Methylene Blue-Enhanced Ultrafiltration Improves Outcomes After Cardiopulmonary Bypass
Methylene Blue, Conventional ultrafiltration, Zero-balance ultrafiltration - Cardiopulmonary Bypass Surgery, Aortic Valve Surgery
Phase 2CompletedUniversity of Sao Paulo1242021-04-122025-10-08
Hidradenitis Suppurativa Wound Care
methylene blue, gentian violet, and ovine forestomach wound dressings - Hidradenitis Suppurativa (HS)
Phase 2CompletedWake Forest University Health Sciences52021-02-042025-10-22
Methylene Blue Treatment of COVID-19
Methylene Blue, Control Test - SARS-CoV2
Phase 2CompletedFondazione Epatocentro Ticino292020-11-052025-08-17
Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19
exchange blood transfusion from normal donor, plasma from convalescent patients with COVID-19, Methylene Blue 5 MG/ML - COVID-19
Phase 2UnknownAin Shams University152020-05-202020-07-09
Methylene Blue as a Third-line Vasopressor in Septic Shock
Methylene Blue, Phenylephrine - Septic Shock
Phase 2UnknownCarilion Clinic2502019-12-012022-07-26
Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery
Hydroxocobalamin, Methylene Blue, Normal saline - Vasoplegia, Hypotension
Phase 2WithdrawnDartmouth-Hitchcock Medical Center2019-11-012020-03-02
MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)
Best Practice, Methylene Blue - Malignant Neoplasm, Oral Pain
Phase 2CompletedM.D. Anderson Cancer Center692019-02-282023-04-25
Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate
Methylene Blue - Neonatal Sepsis, Refractory Shock
Phase 2UnknownAin Shams University362019-02-192019-10-01
Methylene Blue in Early Septic Shock
0.9% sodium chloride, Methylene Blue - Septic Shock
Phase 2 / Phase 3CompletedHospital Civil de Guadalajara912017-03-172022-11-04
Methylene Blue Against Falciparum Malaria in Burkina Faso
Methylene Blue, Primaquine - Malaria, Falciparum
Phase 2CompletedHeidelberg University1002016-10-012020-03-25

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Shock, Septic (6)  ·  Breast Neoplasms (2)  ·  COVID-19 (2)  ·  Malaria (2)  ·  Neonatal Sepsis (2)  ·  Shock (2)  ·  Abscess (1)  ·  Acute Kidney Injury (1)  ·  Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Coronary Artery Disease (1)  ·  Cross Infection (1)  ·  Disease (1)  ·  Elimination Disorders (1)  ·  Heart Valve Diseases (1)

Sponsors

Heidelberg University (3)  ·  Ain Shams University (2)  ·  Fondazione Epatocentro Ticino (2)  ·  University of Rochester (2)  ·  Carilion Clinic (1)  ·  Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Federal University of São Paulo (1)  ·  Hospital Civil de Guadalajara (1)  ·  Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences (1)  ·  Louisiana State University Health Sciences Center in New Orleans (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute, Egypt (1)  ·  Ondine Biomedical Inc. (1)  ·  Peking University Cancer Hospital & Institute (1)

Countries

United States (11)  ·  Brazil (3)  ·  Burkina Faso (3)  ·  Egypt (3)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  China (1)  ·  India (1)  ·  Iran (1)  ·  Mali (1)  ·  Mexico (1)  ·  Russia (1)

Top investigators

Alassane Dicko, MD (1)  ·  Ashwani K Sharma, MD (1)  ·  Ayman I Tharwat, MD (1)  ·  Carla Pontes, MD (1)  ·  Carlos Roldan (1)  ·  Dennis Holmes (1)  ·  Ehab H Shaker, MD (1)  ·  Eugene A Woltering, MD (1)  ·  Flavia R Machado, MD, PhD (1)  ·  Frank Biscardi (1)  ·  Laurie Christensen, BS (1)  ·  Lori A Zoellner, PhD (1)  ·  Miguel Ibarra-Estrada, MD (1)  ·  Mohamed M Moussa, MD (1)  ·  Olaf Mueller, MD, MPH (1)

Results publications

PMID 36915146, PMID 11588440, PMID 12500513, PMID 12519925, PMID 14759425, PMID 16134766, PMID 17698886, PMID 18286187, PMID 18477932, PMID 19415120, PMID 21246318, PMID 25267980, PMID 26683506, PMID 27673307, PMID 28686823, PMID 28723883, PMID 29151412, PMID 29422384, PMID 29508706, PMID 29936590, PMID 30231909, PMID 31600221, PMID 32270211, PMID 32453920, PMID 32520577, PMID 34719443, PMID 36237547, PMID 36324139, PMID 36505110, PMID 36705345, PMID 39780053, PMID 8648456, PMID 9250657

NIH funding

R34MH087375 (1)